FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
Status:
Completed
Trial end date:
2019-10-04
Target enrollment:
Participant gender:
Summary
A research study of a new method of visualizing internal organs called 18F-FLT PET/CT that
yields better tracking of cancer treatment progress. PET/CT stands for positron emission
tomography with low dose computed tomography and has been used for many years. 18F-FLT PET/CT
uses a new tracer, fluorothymidine, which is taken up by cells that are actively
proliferating or dividing such as cancer cells. We hope to learn whether this tracer is
superior to the conventional tracer for monitoring treatment of diffuse large B-cell lymphoma
(DLBCL).